Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6199)
All Articles published online
|
Aug 7, 2012 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Beaugerie L, Sokol H. Clinical, serological and genetic predictors of inflammatory bowel disease course. World J Gastroenterol 2012; 18(29): 3806-3813 [PMID: 22876031 DOI: 10.3748/wjg.v18.i29.3806] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i29/3806.htm |
| Number | Citing Articles |
| 1 |
Lynsey Stevenson. How to Improve Your Success in Treating Mild and Moderate Inflammatory Bowel Disease. EMJ Gastroenterology 2016; : 2 doi: 10.33590/emjgastroenterol/10312456
|
| 2 |
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin-Biroulet, Silvio Danese. Crohn’s disease. Nature Reviews Disease Primers 2020; 6(1) doi: 10.1038/s41572-020-0156-2
|
| 3 |
Ondrej Hradsky, Ivana Copova, Kristyna Zarubova, Jiri Nevoral, Jiri Bronsky. Time to Relapse in Children with Crohn’s Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids. Digestive Diseases and Sciences 2016; 61(7): 2041 doi: 10.1007/s10620-016-4103-8
|
| 4 |
Raja Hazime, Fatima-Ezzohra Eddehbi, Saad El Mojadili, Nadia Lakhouaja, Ikram Souli, Abdelmouïne Salami, Bouchra M’Raouni, Imane Brahim, Mohamed Oujidi, Morad Guennouni, Ahmed Aziz Bousfiha, Brahim Admou. Inborn errors of immunity and related microbiome. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.982772
|
| 5 |
Elisa Liverani, Eleonora Scaioli, Richard John Digby, Matteo Bellanova, Andrea Belluzzi. How to predict clinical relapse in inflammatory bowel disease patients. World Journal of Gastroenterology 2016; 22(3): 1017-1033 doi: 10.3748/wjg.v22.i3.1017
|
| 6 |
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi, Rahul Kalla. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Research 2020; 9: 54 doi: 10.12688/f1000research.20928.1
|
| 7 |
Peter Brown, Tanya Clark, Grace Dowson, Lisa Warren, John Hamlin, Mark Hull, Venkataraman Subramanian. Relationship of Body Mass Index to Clinical Outcomes after Infliximab Therapy in Patients with Crohn’s Disease. Journal of Crohn's and Colitis 2016; 10(10): 1144 doi: 10.1093/ecco-jcc/jjw079
|
| 8 |
Guillaume Bouguen, Barrett G. Levesque, Brian G. Feagan, Arthur Kavanaugh, Laurent Peyrin–Biroulet, Jean–Frederic Colombel, Stephen B. Hanauer, William J. Sandborn. Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease. Clinical Gastroenterology and Hepatology 2015; 13(6): 1042 doi: 10.1016/j.cgh.2013.09.006
|
| 9 |
Cláudia Camila Dias, Pedro Pereira Rodrigues, Samuel Fernandes, Francisco Portela, Paula Ministro, Diana Martins, Paula Sousa, Paula Lago, Isadora Rosa, Luis Correia, Paula Moura Santos, Fernando Magro, Francesco Pappalardo. The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis. PLOS ONE 2017; 12(2): e0172165 doi: 10.1371/journal.pone.0172165
|
| 10 |
Satoshi Tamura, Natsuki Ishida, Takahiro Miyazu, Shunya Onoue, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78603-9
|
| 11 |
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancer. Journal of Coloproctology 2017; 37(01): 055 doi: 10.1016/j.jcol.2016.06.005
|
| 12 |
Rafael López-Cortés, Raquel Herrero-Hahn, Rosanna De la Rosa-Eduardo, Rafael Montoya-Juárez, María García-Caro, Blanca Marín-Fernández, César Hueso-Montoro. Cultural Adaptation and Validation of the Inflammatory Bowel Disease Disability Index in a Spanish Population and Its Association with Sociodemographic and Clinical Factors. International Journal of Environmental Research and Public Health 2019; 16(4): 635 doi: 10.3390/ijerph16040635
|
| 13 |
Marília L. Cravo, Paula A. Ferreira, Patricia Sousa, Paula Moura-Santos, Sónia Velho, Lurdes Tavares, João R. de Deus, Paula Ministro, Paula Peixe, Luis A. Correia, José F. Velosa, Rui F. Maio, Miguel Brito. IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis. European Journal of Gastroenterology & Hepatology 2014; 26(1): 26 doi: 10.1097/MEG.0000000000000004
|
| 14 |
Elizabeth F. Snyder, Stephanie Davis, Kristina Aldrich, Manjakkollai Veerabagu, Tiziana Larussa, Ludovico Abenavoli, Luigi Boccuto. Crohn disease. The Nurse Practitioner 2021; 46(12): 22 doi: 10.1097/01.NPR.0000798212.61425.4f
|
| 15 |
G. M. C. Adriaans, R. J. Almeida, D. Jonkers, T. van den Heuvel, A. G. L. Bodelier, M. J. Pierik. Analysis of biomarkers and composite scores in IBD patients using probabilistic fuzzy systems. 2022 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE) 2022; : 1 doi: 10.1109/FUZZ-IEEE55066.2022.9882584
|
| 16 |
Michal Kori, Maya Avidan, Chani Topf‐Olivestone. Long‐Term Follow‐up and Predictors of Complicated Disease Behavior in Pediatric Crohn's Disease Patients. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(4): 471 doi: 10.1097/MPG.0000000000003374
|
| 17 |
A. C. Moss. Optimizing the use of biological therapy in patients with inflammatory bowel disease. Gastroenterology Report 2015; 3(1): 63 doi: 10.1093/gastro/gou087
|
| 18 |
Michael Christian Sulz, Joel Duetschler, Frank Seibold. Therapiealgorithmen für die Behandlung des Morbus Crohn im klinischen Alltag. Schweizer Gastroenterologie 2020; 1(2): 51 doi: 10.1007/s43472-020-00009-9
|
| 19 |
Vivek Chhaya, Sonia Saxena, Elizabeth Cecil, Venkataraman Subramanian, Vasa Curcin, Azeem Majeed, Richard C. Pollok. Emerging trends and risk factors for perianal surgery in Crohn’s disease: a 20-year national population-based cohort study. European Journal of Gastroenterology & Hepatology 2016; 28(8): 890 doi: 10.1097/MEG.0000000000000651
|
| 20 |
Joana Torres, Flavio Caprioli, Konstantinos H. Katsanos, Triana Lobatón, Dejan Micic, Marco Zerôncio, Gert Van Assche, James C. Lee, James O. Lindsay, David T. Rubin, Remo Panaccione, Jean-Frédéric Colombel. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 2016; 10(12): 1385 doi: 10.1093/ecco-jcc/jjw116
|
| 21 |
Emily C Oxford, Deanna D Nguyen, Jenny Sauk, Joshua R Korzenik, Vijay Yajnik, Sonia Friedman, Ashwin N Ananthakrishnan. Impact of Coexistent Celiac Disease on Phenotype and Natural History of Inflammatory Bowel Diseases. American Journal of Gastroenterology 2013; 108(7): 1123 doi: 10.1038/ajg.2013.20
|
| 22 |
Yusuf Kayar, Bulent Baran, Asli Cifcibasi Ormeci, Filiz Akyuz, Kadir Demir, Fatih Besisik, Sabahattin Kaymakoglu. Risk factors associated with progression to intestinal complications of Crohn disease. Chinese Medical Journal 2019; 132(20): 2423 doi: 10.1097/CM9.0000000000000489
|
| 23 |
Andreas Stallmach, Luisa Nickel, Thomas Lehmann, Bernd Bokemeyer, Martin Bürger, Dietrich Hüppe, Wolfgang Kruis, Susanna Nikolaus, Jan C Preiss, Andreas Sturm, Niels Teich, Carsten Schmidt. Parameters of a severe disease course in ulcerative colitis. World Journal of Gastroenterology 2014; 20(35): 12574-12580 doi: 10.3748/wjg.v20.i35.12574
|
| 24 |
Delphine Sterlin, Jehane Fadlallah, Emma Slack, Guy Gorochov. The antibody/microbiota interface in health and disease. Mucosal Immunology 2020; 13(1): 3 doi: 10.1038/s41385-019-0192-y
|
| 25 |
Kouichi Asano, Motohiro Esaki, Junji Umeno, Atsushi Hirano, Yuji Maehata, Tomohiko Moriyama, Shotaro Nakamura, Takayuki Matsumoto, Takanari Kitazono. Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis. Journal of Gastroenterology 2015; 50(11): 1094 doi: 10.1007/s00535-015-1062-3
|
| 26 |
Fernando Magro, Maria Manuela Estevinho, Gaia Catalano, Marta Patita, Bruno Arroja, Paula Lago, Isadora Rosa, Helena Tavares de Sousa, Paula Ministro, Irina Mocanu, Ana Vieira, Joana Castela, Joana Moleiro, Joana Roseira, Eugénia Cancela, Paula Sousa, Francisco Portela, Luís Correia, Paula Moreira, Mafalda Santiago, Sandra Dias, Joana Afonso, Silvio Danese, Laurent Peyrin‐Biroulet, Cláudia Camila Dias. How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study. United European Gastroenterology Journal 2023; 11(6): 531 doi: 10.1002/ueg2.12420
|
| 27 |
Sophie Vieujean, Edouard Louis. Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 2023; 16: 175628482311733 doi: 10.1177/17562848231173331
|
| 28 |
S. Maignant, C. Pélatan, E. Breton, B. Cagnard, E. Chaillou, J.-L. Giniès, G. Le Hénaff, J.-F. Ségura, S. Willot, L. Bridoux, A. Jobert, E. Darviot, N. Delaperrière, D. Lapeyre, E. Carré, I. Grimal, R. Hankard, A.-C. Wagner, M. Balençon, D. Caldari, Y. Tourtelier, A. Dabadie. Connaissances des adolescents atteints de maladie inflammatoire chronique intestinale : résultats d’une enquête transversale multicentrique. Archives de Pédiatrie 2015; 22(5): 468 doi: 10.1016/j.arcped.2015.01.013
|
| 29 |
Antonio Rispo, Anna Testa, Giovanni Domenico De Palma, Sara Donetto, Maria Diaferia, Dario Musto, Olga Nardone, Francesco Maione, Nicola Caporaso, Fabiana Castiglione. Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohnʼs Disease. Inflammatory Bowel Diseases 2015; 21(11): 2570 doi: 10.1097/MIB.0000000000000538
|
| 30 |
Natashia M. Seemann, Sebastian K. King, Abdul Elkadri, Thomas Walters, Joel Fish, Jacob C. Langer. The operative management of children with complex perianal Crohn's disease. Journal of Pediatric Surgery 2016; 51(12): 1993 doi: 10.1016/j.jpedsurg.2016.09.021
|
| 31 |
Alessandro Armuzzi, Daniela Pugliese. Crohn's Disease and Ulcerative Colitis. 2017; : 351 doi: 10.1007/978-3-319-33703-6_33
|
| 32 |
Fernando T. Veloso. Clinical predictors of Crohn’s disease course. European Journal of Gastroenterology & Hepatology 2016; 28(10): 1122 doi: 10.1097/MEG.0000000000000698
|
| 33 |
Trinidad Montero-Meléndez, Xavier Llor, Esther García-Planella, Mauro Perretti, Antonio Suárez, Raffaele A. Calogero. Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling. PLoS ONE 2013; 8(10): e76235 doi: 10.1371/journal.pone.0076235
|
| 34 |
Jehane Fadlallah, Delphine Sterlin, Claire Fieschi, Christophe Parizot, Karim Dorgham, Hela El Kafsi, Gaëlle Autaa, Pascale Ghillani-Dalbin, Catherine Juste, Patricia Lepage, Marion Malphettes, Lionel Galicier, David Boutboul, Karine Clément, Sébastien André, Florian Marquet, Christophe Tresallet, Alexis Mathian, Makoto Miyara, Eric Oksenhendler, Zahir Amoura, Hans Yssel, Martin Larsen, Guy Gorochov. Synergistic convergence of microbiota-specific systemic IgG and secretory IgA. Journal of Allergy and Clinical Immunology 2019; 143(4): 1575 doi: 10.1016/j.jaci.2018.09.036
|
| 35 |
J.C. Andreu-Ballester, I. Catalán-Serra, R. Gil-Borrás, P. Marqués-García, C. García-Ballesteros, F. López Chuliá, C. Cuéllar. Gammadelta T cells as a predictor of surgical relapse of Crohn's disease. Clinics and Research in Hepatology and Gastroenterology 2020; 44(4): 586 doi: 10.1016/j.clinre.2019.11.003
|
| 36 |
Jose C. Gallego, Ana Echarri. Role of magnetic resonance imaging in the management of perianal Crohn’s disease. Insights into Imaging 2018; 9(1): 47 doi: 10.1007/s13244-017-0579-9
|
| 37 |
Michael J Mintz, Ashwin N Ananthakrishnan. Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis. Inflammatory Bowel Diseases 2021; 27(4): 469 doi: 10.1093/ibd/izaa094
|
| 38 |
Garth R. Swanson, Nicole Kochman, Jaimin Amin, Vijit Chouhan, Wesley Yim, Phillip A. Engen, Maliha Shaikh, Ankur Naqib, Laura Tran, Robin M. Voigt, Christopher B. Forsyth, Stefan J. Green, Ali Keshavarzian. Disrupted Circadian Rest-Activity Cycles in Inflammatory Bowel Disease Are Associated With Aggressive Disease Phenotype, Subclinical Inflammation, and Dysbiosis. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.770491
|
| 39 |
Mimi C. Tan, Hashem B. El-Serag, Jason K. Hou. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2017; 62(3): 607 doi: 10.1007/s10620-016-4414-9
|
| 40 |
A Hillary Steinhart, Remo Panaccione, Laura Targownik, Brian Bressler, Reena Khanna, John K Marshall, Waqqas Afif, Charles N Bernstein, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow, Chadwick Williams. Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus. Inflammatory Bowel Diseases 2019; 25(1): 1 doi: 10.1093/ibd/izy247
|
| 41 |
Fabiola Trejo‑Vazquez, Idalia Garza‑Veloz, Gabriela Villela‑Ramirez, Yolanda Ortiz‑Castro, Panfilo Mauricio‑Saucedo, Edith Cardenas‑Vargas, Mariana Diaz‑Baez, Miguel Cid‑Baez, Rodrigo Casta�eda‑Miranda, Jose Ortiz‑Rodriguez, Luis Solis‑Sanchez, Margarita Martinez‑Fierro. Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5835
|
| 42 |
Sung Chul Park, Yoon Tae Jeen. Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients. Cells 2019; 8(5): 404 doi: 10.3390/cells8050404
|
| 43 |
Jörg Mahlich, Katsuyoshi Matsuoka, Rosarin Sruamsiri. Biologic treatment of Japanese patients with inflammatory bowel disease. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0892-x
|
| 44 |
Inger Camilla Solberg, Marte Lie Høivik, Milada Cvancarova, Bjørn Moum. Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study). Scandinavian Journal of Gastroenterology 2015; 50(12): 1456 doi: 10.3109/00365521.2015.1064991
|
| 45 |
Carla Carnovale, Anna Maffioli, Gloria Zaffaroni, Faizan Mazhar, Vera Battini, Giulia Mosini, Marco Pozzi, Sonia Radice, Emilio Clementi, Piergiorgio Danelli. Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn’s disease patients with perianal lesions: a systematic review. Expert Opinion on Biological Therapy 2020; 20(3): 239 doi: 10.1080/14712598.2020.1718096
|
| 46 |
Nai-Ying Shen, Jian-Bin Bi, Jing-Yao Zhang, Si-Min Zhang, Jing-Xian Gu, Kai Qu, Chang Liu. Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression. World Journal of Gastroenterology 2017; 23(8): 1375-1386 doi: 10.3748/wjg.v23.i8.1375
|
| 47 |
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon. Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors. Gut and Liver 2022; 16(2): 157 doi: 10.5009/gnl210118
|
| 48 |
David B. Sachar. Role of Biomarkers in the Study and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(12): 2511 doi: 10.1097/MIB.0000000000000135
|
| 49 |
Naoto Saigusa, Tadashi Yokoyama, Masaru Shinozaki, Ryoji Miyahara, Tsuyoshi Konishi, Toshio Nakamura, Yasuhisa Yokoyama. Anorectal fistula is an early manifestation of Crohn’s disease that occurs before bowel lesions advance: a study of 11 cases. Clinical Journal of Gastroenterology 2013; 6(4): 309 doi: 10.1007/s12328-013-0404-z
|
| 50 |
Remo Panaccione, A Hillary Steinhart, Brian Bressler, Reena Khanna, John K Marshall, Laura Targownik, Waqqas Afif, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow, Chadwick Williams, Charles N Bernstein. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. Journal of the Canadian Association of Gastroenterology 2019; 2(3): e1 doi: 10.1093/jcag/gwz019
|
| 51 |
Cláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, Paula Moura Santos, Samuel Fernandes, Paula Lago, Cidalina Caetano, Ângela Rodrigues, Francisco Portela, Ana Oliveira, Paula Ministro, Eugénia Cancela, Ana Isabel Vieira, Rita Barosa, José Cotter, Pedro Carvalho, Isabelle Cremers, Daniel Trabulo, Paulo Caldeira, Artur Antunes, Isadora Rosa, Joana Moleiro, Paula Peixe, Rita Herculano, Raquel Gonçalves, Bruno Gonçalves, Helena Tavares Sousa, Luís Contente, Henrique Morna, Susana Lopes, Fernando Magro. Development and Validation of Risk Matrices for Crohn’s Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. Journal of Crohn's and Colitis 2016; : jjw171 doi: 10.1093/ecco-jcc/jjw171
|
| 52 |
Maša Umićević Mirkov, Bram Verstockt, Isabelle Cleynen. Genetics of inflammatory bowel disease: beyond NOD2. The Lancet Gastroenterology & Hepatology 2017; 2(3): 224 doi: 10.1016/S2468-1253(16)30111-X
|
| 53 |
Ren Mao, Yun Qiu, Bai-Li Chen, Sheng-Hong Zhang, Rui Feng, Yao He, Zhi- Rong Zeng, Shomron Ben-Horin, Min-Hu Chen. Factors associated with the achievement of mucosal healing in Crohn’s disease: the benefit of endoscopic monitoring in treating to target. Therapeutic Advances in Gastroenterology 2017; 10(6): 453 doi: 10.1177/1756283X17698089
|
| 54 |
Bianca JC van den Bosch, Marieke JH Coenen. Pharmacogenetics of inflammatory bowel disease. Pharmacogenomics 2021; 22(1): 55 doi: 10.2217/pgs-2020-0095
|
| 55 |
A Hillary Steinhart, Remo Panaccione, Laura Targownik, Brian Bressler, Reena Khanna, John K Marshall, Waqqas Afif, Charles N Bernstein, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow, Chadwick Williams. Clinical Practice Guideline for the Medical Management of Perianal
Fistulizing Crohn’s Disease: The Toronto Consensus. Journal of the Canadian Association of Gastroenterology 2018; 1(4): 141 doi: 10.1093/jcag/gwy047
|
| 56 |
Isaiah P. Schuster, Leslie Klyachman, Ramona Rajapakse, Farah Monzur. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 89 doi: 10.1007/978-3-030-81780-0_4
|
| 57 |
Ho-Su Lee, Isabelle Cleynen. Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?. Cells 2019; 8(6): 535 doi: 10.3390/cells8060535
|
| 58 |
Sudarshan Paramsothy, Adam K. Rosenstein, Saurabh Mehandru, Jean-Frederic Colombel. The current state of the art for biological therapies and new small molecules in inflammatory bowel disease. Mucosal Immunology 2018; 11(6): 1558 doi: 10.1038/s41385-018-0050-3
|
| 59 |
Marta Sobczak, Piotr K. Zakrzewski, Adam I. Cygankiewicz, Anna Mokrowiecka, Chunqiu Chen, Maciej Sałaga, Ewa Małecka-Panas, Radzisław Kordek, Wanda M. Krajewska, Jakub Fichna. Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases. Pharmacological Reports 2014; 66(5): 741 doi: 10.1016/j.pharep.2014.03.007
|
| 60 |
Remo Panaccione, A. Hillary Steinhart, Brian Bressler, Reena Khanna, John K. Marshall, Laura Targownik, Waqqas Afif, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I. Leontiadis, Edward V. Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H. Seow, Chadwick Williams, Charles N. Bernstein. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. Clinical Gastroenterology and Hepatology 2019; 17(9): 1680 doi: 10.1016/j.cgh.2019.02.043
|
| 61 |
Fernando Magro, Cláudia Camila Dias, Francisco Portela, Mário Miranda, Samuel Fernandes, Sonia Bernardo, Paula Ministro, Paula Lago, Isadora Rosa, Inês Pita, Luis Correia, Pedro Pereira Rodrigues. Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes—Bayesian Network Analysis. Journal of Crohn's and Colitis 2019; 13(4): 401 doi: 10.1093/ecco-jcc/jjy168
|